Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page
- Check5 days agoChange DetectedThe page displays the completed eteplirsen rollover study for Duchenne muscular dystrophy, with details on its design, participants, treatment, outcomes, and participating locations. It also includes study record dates, investigators, and related publications.SummaryDifference44%

- Check12 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe clinical study record is no longer displayed and the page shows a 403 Forbidden message. An NIH website transition notice is also shown.SummaryDifference18%

- Check33 days agoChange DetectedThe record now displays details for the completed eteplirsen study, including its objectives, treatment plan, eligibility criteria, outcomes, and study locations. It also includes publication and study-history information.SummaryDifference45%

- Check40 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the study page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-denied message. The prior study details and related navigation are no longer visible on this page.SummaryDifference17%

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.